{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:07:04Z","timestamp":1780582024601,"version":"3.54.1"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      This study aimed to investigate the clinical characteristics of\n                      <jats:italic>Chlamydia pneumoniae<\/jats:italic>\n                      pneumonia (CPP) in children and analyze the risk factors for progression to severe pneumonia.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A total of 133 children with CPP were retrospectively enrolled from Hebei Children's Hospital between 2023 and 2025. Disease severity was classified according to the Guidelines for the Management of Community-Acquired Pneumonia in Children (2024 revision), and patients were divided into a non-severe group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200999) and a severe group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200934). Demographic characteristics, clinical manifestations, and laboratory findings were compared between groups. Multivariate binary logistic regression analysis was performed to identify independent factors associated with severe disease.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Compared with the non-severe group, children in the severe group had a higher peak temperature and longer duration of fever (both\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001). No significant differences were observed in the proportion of mixed infections or the distribution of pathogens between the two groups (all\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;gt;\u20090.05). Laboratory findings showed a lower lymphocyte percentage and higher levels of WBC, CRP, and IgA in the severe group (all\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.05). Multivariate analysis identified decreased lymphocyte percentage (OR\u2009=\u20090.943, 95% CI 0.895\u20130.994) and elevated IgA (OR\u2009=\u20092.227, 95% CI 1.284\u20133.972) as factors associated with severe CPP.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Decreased lymphocyte percentage and elevated serum IgA are associated with severe CPP in children, suggesting potential roles in risk stratification. Further multicenter prospective studies are warranted to validate and confirm these findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2026.1834503","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T06:01:44Z","timestamp":1780466504000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk factors for severe Chlamydia pneumoniae pneumonia in children: a retrospective case\u2013control study"],"prefix":"10.3389","volume":"14","author":[{"given":"Di","family":"Hu","sequence":"first","affiliation":[{"name":"Graduate School, Hebei Medical University","place":["Shijiazhuang, Hebei, China"]},{"name":"Department No. 3 of Respiratory Medicine, Hebei Children\u2019s Hospital","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingqian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department No. 3 of Respiratory Medicine, Hebei Children\u2019s Hospital","place":["Shijiazhuang, Hebei, China"]},{"name":"Hebei Clinical Medicine Research Center for Children\u2019s Health and Diseases","place":["Shijiazhuang, Hebei, China"]},{"name":"Hebei Key Laboratory of Pediatric Allergy and Immunology, Hebei Children's Hospital","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Ma","sequence":"additional","affiliation":[{"name":"Graduate School, Hebei Medical University","place":["Shijiazhuang, Hebei, China"]},{"name":"Department No. 3 of Respiratory Medicine, Hebei Children\u2019s Hospital","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiao","family":"Ba","sequence":"additional","affiliation":[{"name":"Graduate School, Hebei Medical University","place":["Shijiazhuang, Hebei, China"]},{"name":"Department No. 3 of Respiratory Medicine, Hebei Children\u2019s Hospital","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peijuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Graduate School, Hebei Medical University","place":["Shijiazhuang, Hebei, China"]},{"name":"Department No. 3 of Respiratory Medicine, Hebei Children\u2019s Hospital","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1080\/21645515.2016.1174356","article-title":"Epidemiology of community-acquired pneumonia and implications for vaccination of children living in developing and newly industrialized countries: a systematic literature review","volume":"12","author":"DeAntonio","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"B2","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3345\/cep.2019.00360","article-title":"Current perspectives on atypical pneumonia in children","volume":"63","author":"Shim","year":"2020","journal-title":"Clin Exp Pediatr"},{"key":"B3","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1136\/jcp.2004.024380","article-title":"A population based seroepidemiological survey of Chlamydia pneumoniae infections in schoolchildren","volume":"58","author":"Dal Molin","year":"2005","journal-title":"J Clin Pathol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jiac.2023.01.012","article-title":"Surge of Chlamydia pneumoniae pneumonia in children hospitalized with community-acquired pneumonia at a single center in Korea in 2016","volume":"29","author":"Han","year":"2023","journal-title":"J Infect Chemother"},{"key":"B5","doi-asserted-by":"publisher","first-page":"16299","DOI":"10.1038\/s41598-024-65006-3","article-title":"Epidemiological characteristics of common respiratory pathogens in children","volume":"14","author":"Lv","year":"2024","journal-title":"Sci Rep"},{"key":"B6","doi-asserted-by":"publisher","first-page":"107897","DOI":"10.1016\/j.ijid.2025.107897","article-title":"Significant rise of Chlamydia pneumoniae infection in 2024 in Marseille, France","volume":"155","author":"Edouard","year":"2025","journal-title":"Int J Infect Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-026-05419-2","article-title":"Upsurge of Chlamydia pneumoniae respiratory tract infections in 2024\/2025 in southern Germany","author":"Wellinghausen","year":"2026","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1729558","DOI":"10.3389\/fpubh.2026.1729558","article-title":"Epidemiology of Chlamydia pneumoniae infection in children with acute respiratory tract infections, Chengdu, 2022-2023","volume":"14","author":"Duan","year":"2026","journal-title":"Front Public Health"},{"key":"B9","doi-asserted-by":"publisher","first-page":"938","DOI":"10.3760\/cma.j.cn112150-20210524-00500","article-title":"Clinical characteristics of patients infected with Chlamydia pneumoniae in Beijing from 2015 to 2019","volume":"55","author":"Luo","year":"2021","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"key":"B10","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s42770-020-00229-w","article-title":"High frequency of Chlamydia pneumoniae and risk factors in children with acute respiratory infection","volume":"51","author":"Alves","year":"2020","journal-title":"Braz J Microbiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"21477","DOI":"10.1038\/s41598-023-48701-5","article-title":"Chlamydophila pneumoniae-associated community-acquired pneumonia in paediatric patients of a tertiary care hospital in Mexico: molecular diagnostic and clinical insights","volume":"13","author":"Merida Vieyra","year":"2023","journal-title":"Sci Rep"},{"key":"B12","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3760\/cma.j.cn112140-20240728-00523","article-title":"Guidelines for management of community-acquired pneumonia in children (2024 revision).","volume":"62","year":"2024","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"B13","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1186\/s12879-025-11405-4","article-title":"Comparative analysis of Chlamydia pneumoniae pneumonia (CPP) and Mycoplasma pneumoniae pneumonia in children and risk factors of severe CPP","volume":"25","author":"Huang","year":"2025","journal-title":"BMC Infect Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nrmicro.2016.30","article-title":"Chlamydia cell biology and pathogenesis","volume":"14","author":"Elwell","year":"2016","journal-title":"Nat Rev Microbiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/S1473-3099(24)00176-2","article-title":"Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990\u20132021: a systematic analysis from the global burden of disease study 2021","volume":"24","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e066721","DOI":"10.1136\/bmjopen-2022-066721","article-title":"Prevalence of atypical pathogens in patients with severe pneumonia: a systematic review and meta-analysis","volume":"13","author":"Wang","year":"2023","journal-title":"BMJ Open"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2400682","DOI":"10.2807\/1560-7917.ES.2025.30.23.2400682","article-title":"ESCMID Study group for Mycoplasma and Chlamydia infections (ESGMAC). epidemiological changes in Chlamydia pneumoniae molecular detections before, during and after the COVID-19 pandemic in 27 European sites and Taiwan, 2018 to 2023","volume":"30","author":"Tagini","year":"2025","journal-title":"Euro Surveill"},{"key":"B18","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/2047-783x-15-s2-112","article-title":"Respiratory infection caused by Chlamydophila pneumoniae in children and adolescents in the lower silesia region of Poland","volume":"15","author":"Choroszy-Krol","year":"2010","journal-title":"Eur J Med Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.tim.2014.04.013","article-title":"Chlamydia genomics: providing novel insights into chlamydial biology","volume":"22","author":"Bachmann","year":"2014","journal-title":"Trends Microbiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e0250034","DOI":"10.1371\/journal.pone.0250034","article-title":"Chlamydia pneumoniae and chronic asthma: updated systematic review and meta-analysis of population attributable risk","volume":"16","author":"Hahn","year":"2021","journal-title":"PLoS One"},{"key":"B21","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s10096-025-05360-w","article-title":"Epidemiological characteristics of chlamydial infection in hospitalized children in China: a nationwide retrospective study","volume":"45","author":"Zheng","year":"2026","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"fmae046","DOI":"10.1093\/tropej\/fmae046","article-title":"Risk factors of severe Chlamydia trachomatis pneumonia in children: a retrospective case-control study","volume":"70","author":"Chen","year":"2024","journal-title":"J Trop Pediatr"},{"key":"B23","doi-asserted-by":"publisher","first-page":"558941","DOI":"10.3389\/fped.2020.558941","article-title":"The association between Mycoplasma pneumoniae and Chlamydia pneumoniae, a life-threatening condition in small children\u2014a case report and a review of the literature","volume":"8","author":"M\u0103rginean","year":"2020","journal-title":"Front Pediatr"},{"key":"B24","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jinf.2019.04.006","article-title":"Lymphopenic community-acquired pneumonia is associated with a dysregulated immune response and increased severity and mortality","volume":"78","author":"M\u00e9ndez","year":"2019","journal-title":"J Infect"},{"key":"B25","doi-asserted-by":"publisher","first-page":"953103","DOI":"10.3389\/fmed.2022.953103","article-title":"Lymphocyte trajectories are associated with prognosis in critically ill patients: a convenient way to monitor immune status","volume":"9","author":"Pei","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1615\/ForumImmunDisTher.2017020161","article-title":"Chlamydia pneumoniae infection and inflammatory diseases","volume":"7","author":"Porritt","year":"2016","journal-title":"For Immunopathol Dis Therap"},{"key":"B27","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3760\/cma.j.cn112140-20250609-00493","article-title":"Epidemiological characteristics, molecular mechanisms, diagnosis, and treatment of Chlamydia pneumoniae pneumonia in children","volume":"64","author":"Ma","year":"2026","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"B28","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/path.1877","article-title":"The function of immunoglobulin A in immunity","volume":"208","author":"Woof","year":"2006","journal-title":"J Pathol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e22390","DOI":"10.1097\/MD.0000000000022390","article-title":"Immunoglobulins concentration and B cell counts as severity markers in adult community-acquired pneumonia: cross sectional study","volume":"99","author":"Luchsinger","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10875-009-9338-0","article-title":"Role of IgA and IgA fc receptors in inflammation","volume":"30","author":"Monteiro","year":"2010","journal-title":"J Clin Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/j.1442-200X.2012.03675.x","article-title":"Chlamydia pneumoniae infection presenting with angioedema in an adolescent","volume":"54","author":"Uysal","year":"2012","journal-title":"Pediatr Int"},{"key":"B32","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1159\/000506460","article-title":"Skin and mucous membrane eruptions associated with Chlamydophila pneumoniae respiratory infections: literature review","volume":"237","author":"De Luigi","year":"2021","journal-title":"Dermatology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e01624","DOI":"10.1016\/j.idcr.2022.e01624","article-title":"Immunoglobulin A vasculitis induced by atypical pneumonia infection with Chlamydophila pneumonia","volume":"30","author":"Kang","year":"2022","journal-title":"IDCases"},{"key":"B34","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3760\/cma.j.cn112140-20241106-00797","article-title":"Clinical features of Chlamydia pneumoniae pneumonia in 10 children","volume":"63","author":"Wen","year":"2025","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"B35","doi-asserted-by":"publisher","first-page":"ftv121","DOI":"10.1093\/femspd\/ftv121","article-title":"Iga modulates respiratory dysfunction as a sequela to pulmonary chlamydial infection as neonates","volume":"74","author":"Lanka","year":"2016","journal-title":"Pathog Dis"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1834503\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:29:02Z","timestamp":1780579742000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1834503\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":35,"alternative-id":["10.3389\/fped.2026.1834503"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1834503","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"article-number":"1834503"}}